Our latest paper, titled “The value of public-private collaborative Real-World Evidence platforms to monitor vaccine performance post authorization: DRIVE – a European initiative” is now available at the Expert Reviews of Vaccines journal.

The paper is a plea on behalf of public-private collaboration, which has proven to play a critical role in combating infectious diseases. In it, DRIVE partners explain how to build a collaborative platform with transparent governance, state-of-the-art methodology, and a large network of participating sites.

According to the authors “The DRIVE partners propose that a debate on the benefits of Public-Private-Partnership-generated real-world evidence for vaccine effectiveness monitoring should be pursued to clarify roles and responsibilities, set up expectations, and decide the future environment for vaccine monitoring in Europe. In parallel, the driving factors behind PPP hesitancy should be studied.”

Read the full paper here.